Lunch & Learn: AI-driven Clinical Trials
Why Join?
Late-stage trials are the biggest milestone for small Biotech's and MedTech — and also the riskiest. Nearly 60% of trials require costly amendments, most caused by avoidable design flaws.
Join us for a practical, lunch-hour session on how AI-driven protocol development and smart, fast site selection can help you stay ahead.
You’ll discover:
- How AI is transforming trial design and execution
- Why protocols often become “risk multipliers”
- How smart, fast site selection accelerates success
- A real-world case study: Smarter protocols in action
